Setolac-MR 10 Tablets

babies: not recommended for children. lactating mothers: information regarding its safety profile while breastfeeding is not available.
need to seek doctors’ advice. pregnancy: need to seek doctors’ advice before taking this medication.
driving: etodolac and thiocolchicoside tablets may cause dizziness and drowsiness. do not drive if these symptoms occur.
alcohol: avoid consuming alcohol while on this tablet as it can increase the risk of stomach bleeding. liver: these tablets should use with caution in patients with liver disease.
you may require dosage adjustment and regular monitoring of liver function. seek doctor advice before using this medication. kidney: etodolac and thiocolchicoside tablet is safe for use in kidney disease.
however, you may require regular monitoring of kidney function. seek doctor’s advice before using this medication .

Nausea Vomiting Heartburn Stomach pain/epigastric pain Loss of appetite Indigestion Sleepiness .

SETOLAC-MR tablet is a nonsteroidal anti-inflammatory drug (nsaid). this medication works by blocking the chemical messengers that cause pain and inflammation.
thus, this medication is used to treat pain and inflammatory conditions.

If you miss a dose, take SETOLAC-MR as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• SETOLAC-MR tablet is used to treat rheumatoid arthritis, spondylitis, osteoarthritis, fever, muscles pain, toothache, backache earache and throat pain • you should take it after food • take this medication as prescribed by your doctor • avoid alcohol while taking this medication • don’t do tasks that require mental focus if you develop dizziness after taking this medication.

contraindicated • etodolac + ketorolac: concurrent use may result in enhanced gastrointestinal adverse effects. major • etodolac + abciximab: concurrent use may result in an increased risk of bleeding. • etodolac + amiloride: concurrent use may result in reduced diuretic effectiveness, possible nephrotoxicity, hyperkalemia • etodolac + clopidogrel: concurrent use leads to increased risk of bleeding.